Mitchell Sinkler & Starr’s Pfizer PFE Stock Holding History

Mitchell Sinkler & Starr’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$668K	Buy	27,742 +925	+3%	+$24.2K	0.28%	79
2026 Q1	$753K	Hold	26,817	–	–	0.35%	68
2025 Q4	$668K	Sell	26,817 -929	-3%	-$23.4K	0.3%	76
2025 Q3	$707K	Sell	27,746 -326	-1%	-$8.05K	0.32%	69
2025 Q2	$680K	Sell	28,072 -1,227	-4%	-$28.6K	0.33%	73
2025 Q1	$742K	Buy	29,299 +596	+2%	+$15.6K	0.21%	78
2024 Q4	$761K	Sell	28,703 -1,020	-3%	-$27.7K	0.2%	79
2024 Q3	$860K	Buy	29,723 +2,121	+8%	+$61.9K	0.22%	80
2024 Q2	$820K	Sell	27,602 -12,289	-31%	-$338K	0.21%	76
2024 Q1	$1.11M	Sell	39,891 -46,564	-54%	-$1.29M	0.28%	71
2023 Q4	$2.49M	Buy	86,455 +24,732	+40%	+$748K	0.45%	57
2023 Q3	$2.05M	Buy	61,723 +25,958	+73%	+$918K	0.63%	38
2023 Q2	$1.31M	Sell	35,765 -1,170	-3%	-$45.5K	0.37%	57
2023 Q1	$1.51M	Sell	36,935 -7,272	-16%	-$314K	0.45%	51
2022 Q4	$2.27M	Buy	44,207 +18,366	+71%	+$881K	0.73%	36
2022 Q3	$1.13M	Sell	25,841 -235	-0.9%	-$11.4K	0.44%	52
2022 Q2	$1.37M	Sell	26,076 -470	-2%	-$24K	0.5%	43
2022 Q1	$1.37M	Buy	26,546 +4,744	+22%	+$246K	0.43%	51
2021 Q4	$1.29M	Sell	21,802 -579	-3%	-$28.7K	0.38%	56
2021 Q3	$963K	Hold	22,381	–	–	0.87%	44
2021 Q2	$876K	Hold	22,381	–	–	0.8%	47
2021 Q1	$811K	Buy	22,381 +2,100	+10%	+$74.6K	0.79%	48
2020 Q4	$747K	Sell	20,281 -2,070	-9%	-$75.9K	0.71%	51
2020 Q3	$778K	Hold	22,351	–	–	0.79%	41
2020 Q2	$693K	Hold	22,351	–	–	0.79%	42
2020 Q1	$692K	Hold	22,351	–	–	0.91%	38
2019 Q4	$831K	Sell	22,351 -743	-3%	-$26.5K	0.88%	39
2019 Q3	$787K	Sell	23,094 -2,108	-8%	-$76.7K	1.01%	37
2019 Q2	$1.04M	Sell	25,202 -1,160	-4%	-$46.1K	1.18%	32
2019 Q1	$1.06M	Sell	26,362 -2,538	-9%	-$102K	1.23%	31
2018 Q4	$1.2M	Sell	28,900 -242	-0.8%	-$10K	1.48%	26
2018 Q3	$1.22M	Buy	29,142 +1,792	+7%	+$69K	1.27%	29
2018 Q2	$941K	Buy	27,350 +270	+1%	+$9.23K	1.04%	37
2018 Q1	$912K	Buy	27,080 +6,646	+33%	+$228K	1.04%	39
2017 Q4	$702K	Buy	20,434 +1,054	+5%	+$35.9K	1.04%	37
2017 Q3	$656K	Buy	19,380 +1,054	+6%	+$33.9K	1.03%	39
2017 Q2	$584K	Buy	18,326 +738	+4%	+$23.3K	0.96%	42
2017 Q1	$571K	Sell	17,588 -2,862	-14%	-$90.2K	0.93%	43
2016 Q4	$630K	Sell	20,450 -1,054	-5%	-$32.2K	0.88%	41
2016 Q3	$691K	Hold	21,504	–	–	1.08%	34
2016 Q2	$718K	Sell	21,504 -1,686	-7%	-$53.8K	0.98%	38
2016 Q1	$652K	Hold	23,190	–	–	0.9%	40
2015 Q4	$710K	Sell	23,190 -3,795	-14%	-$119K	0.97%	38
2015 Q3	$804K	Hold	26,985	–	–	1.04%	36
2015 Q2	$858K	Sell	26,985 -928	-3%	-$30.2K	1.01%	35
2015 Q1	$921K	Sell	27,913 -58	-0.2%	-$1.84K	1.04%	34
2014 Q4	$827K	Hold	27,971	–	–	0.92%	37
2014 Q3	$785K	Sell	27,971 -2,283	-8%	-$64.1K	0.88%	40
2014 Q2	$852K	Hold	30,254	–	–	0.92%	35
2014 Q1	$922K	Buy	30,254 +3,078	+11%	+$91.8K	1.03%	36
2013 Q4	$790K	Buy	27,176 +13,385	+97%	+$390K	0.89%	42
2013 Q3	$376K	Sell	13,791 -215,895	-94%	-$5.87M	0.43%	59
2013 Q2	$6.1M	Buy	+229,686	New	+$6.35M	1.34%	22

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Mitchell Sinkler & Starr's PFE Position: Q2 2026 in Review

Mitchell Sinkler & Starr increased its Pfizer (PFE) stake by 3.4% in Q2 2026, buying an estimated $24.2K and bringing the position to 27,742 shares worth $668K. The position accounts for 0.28% of the portfolio, ranked #79.

Mitchell Sinkler & Starr first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.1M in Q2 2013. 891 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Mitchell Sinkler & Starr held 27,742 shares of Pfizer worth $668K as of Q2 2026.
Mitchell Sinkler & Starr bought 925 Pfizer shares in Q2 2026, an estimated $24.2K.
Pfizer made up 0.28% of Mitchell Sinkler & Starr's portfolio in Q2 2026, its #79 holding.
Mitchell Sinkler & Starr first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Mitchell Sinkler & Starr's Pfizer position peaked at $6.1M in Q2 2013.
891 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Mitchell Sinkler & Starr's 13F filing for Q2 2026, filed 21 Jul 2026.